BNVA 150 (Boniva 150 mg)
Generic Name: ibandronate
Pill imprint BNVA 150 has been identified as Boniva 150 mg.
Boniva is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BNVA 150 (Boniva 150 mg)
- Generic Name:
- 150 mg
- 14.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
polyethylene glycol 6000
|NDC Code||Manufacturer / Repackager|
|16590-0400||Stat RX USA LLC (repackager)|
|54868-5322||Physicians Total Care Inc (repackager)|
|35356-0423||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Boniva (ibandronate)
- Boniva IV Injection
- Boniva oral/injection
- Boniva (Advanced Reading)
- Boniva Intravenous (Advanced Reading)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...